Ruzena Uddin
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- COVID-19 Clinical Research Studies 5
-
- Lymphoma Diagnosis and Treatment 2
- Co-authors
- William Nigel Patton (2 shared papers)Christian Gisselbrecht (2 shared papers)Ruth Pettengell (2 shared papers)Christian Taverna (2 shared papers)Isabelle Bence‐Bruckler (2 shared papers)Jan Andrzej Walewski (2 shared papers)Anthony H. Goldstone (2 shared papers)Graeme Smith (2 shared papers)
- Journals
- JAMA (6 papers)Journal of Clinical Oncology (2 papers)Intensive Care Medicine (2 papers)Blood (1 paper)European Heart Journal (1 paper)
- Partner nations
- United KingdomGermanyAustralia
In The Last Decade
Ruzena Uddin
15 papers receiving 1k citations
Ruzena Uddin's Hit Papers
Peers
Comparison fields: 5 of 61
- Hematology 234
- Infectious Diseases 303
- Internal Medicine 18
- Nephrology 51
- Pathology and Forensic Medicine 80
Countries citing papers authored by Ruzena Uddin
This map shows the geographic impact of Ruzena Uddin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruzena Uddin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruzena Uddin more than expected).
Fields of papers citing papers by Ruzena Uddin
This network shows the impact of papers produced by Ruzena Uddin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruzena Uddin. The network helps show where Ruzena Uddin may publish in the future.
Co-authors
The 19 scholars most cited alongside Ruzena Uddin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 203 | |
| 2 | 2021 | 166 | |
| 3 | 2022 | 105 | |
| 4 | 2022 | 100 | |
| 5 | Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis Hit paper breakdown → | 2024 | 94 |
| 6 | 2013 | 93 | |
| 7 | 2021 | 72 | |
| 8 | 2021 | 64 | |
| 9 | 2023 | 46 | |
| 10 | 2021 | 43 | |
| 11 | 2023 | 43 | |
| 12 | 2023 | 34 | |
| 13 | 2024 | 9 | |
| 14 | 2023 | 6 | |
| 15 | 2010 | 2 |
About Ruzena Uddin
Ruzena Uddin is a scholar working on Infectious Diseases, Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine, Nephrology and Nutrition and Dietetics, having authored 15 papers that have together received 1.1k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers), Lymphoma Diagnosis and Treatment (2 papers), Cardiac, Anesthesia and Surgical Outcomes (2 papers), Acute Kidney Injury Research (1 paper), Vitamin C and Antioxidants Research (1 paper), Hematopoietic Stem Cell Transplantation (1 paper), Respiratory Support and Mechanisms (1 paper) and Antibiotics Pharmacokinetics and Efficacy (1 paper). The work is most often cited by research in Hematology (234 citations), Infectious Diseases (303 citations), Internal Medicine (18 citations), Nephrology (51 citations) and Pathology and Forensic Medicine (80 citations). Ruzena Uddin has collaborated with scholars based in United Kingdom, Germany and Australia. Frequent co-authors include William Nigel Patton, Christian Gisselbrecht, Ruth Pettengell, Christian Taverna, Isabelle Bence‐Bruckler, Jan Andrzej Walewski, Anthony H. Goldstone, Graeme Smith, Dolores Caballero and Rik Schots. Their work appears in journals such as JAMA, Journal of Clinical Oncology, Intensive Care Medicine, Blood and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.